Hussman Strategic Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.23M | Buy |
+21,000
| New | +$2.23M | 0.51% | 78 |
|
|
2023
Q2 | – | Sell |
-12,400
| Closed | -$1.81M | – | 318 |
|
|
2023
Q1 | $1.81M | Hold |
12,400
| – | – | 0.28% | 141 |
|
|
2022
Q4 | $1.98M | Hold |
12,400
| – | – | 0.32% | 123 |
|
|
2022
Q3 | $1.65M | Buy |
12,400
+2,000
| +19% | +$267K | 0.29% | 142 |
|
|
2022
Q2 | $1.62M | Buy |
10,400
+5,200
| +100% | +$812K | 0.28% | 136 |
|
|
2022
Q1 | $809K | Sell |
5,200
-10,400
| -67% | -$1.62M | 0.16% | 203 |
|
|
2021
Q4 | $1.99M | Sell |
15,600
-9,200
| -37% | -$1.17M | 0.44% | 85 |
|
|
2021
Q3 | $3.23M | Buy |
24,800
+3,200
| +15% | +$417K | 0.71% | 25 |
|
|
2021
Q2 | $3.84M | Hold |
21,600
| – | – | 0.79% | 15 |
|
|
2021
Q1 | $3.55M | Buy |
21,600
+1,100
| +5% | +$181K | 0.73% | 22 |
|
|
2020
Q4 | $3.38M | Buy |
20,500
+250
| +1% | +$41.3K | 0.89% | 7 |
|
|
2020
Q3 | $2.89M | Hold |
20,250
| – | – | 0.76% | 24 |
|
|
2020
Q2 | $2.23M | Buy |
20,250
+5,000
| +33% | +$552K | 0.57% | 61 |
|
|
2020
Q1 | $1.52M | Buy |
15,250
+10,250
| +205% | +$1.02M | 0.41% | 91 |
|
|
2019
Q4 | $746K | Buy |
+5,000
| New | +$746K | 0.24% | 148 |
|
|
2019
Q2 | – | Sell |
-400
| Closed | -$57K | – | 220 |
|
|
2019
Q1 | $57K | Sell |
400
-20,000
| -98% | -$2.85M | 0.01% | 224 |
|
|
2018
Q4 | $2.53M | Buy |
+20,400
| New | +$2.53M | 0.61% | 58 |
|
|
2018
Q1 | – | Sell |
-25,000
| Closed | -$3.37M | – | 232 |
|
|
2017
Q4 | $3.37M | Buy |
+25,000
| New | +$3.37M | 0.96% | 40 |
|